2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¿À¶Ñ±â, ¾óÅ«ÇÏ°Ô Áñ±â´Â ¡®Áö¿ª½Ä ¾óÅ« ±¹¹ä¡¯ Ãâ½Ã (2023-09-05)
Visa Flexible Credential Goes Global: Transforming the Card ... (2024-11-20)
Philip Morris International Announces Senior Global Communic... (2023-12-20)
MINEOLA, N.Y.--(Business Wire / Korea Newswire) May 24, 2023... (2023-05-24)
MBN ¡®¼îÅ·³ªÀÌÆ®¡¯ ¿ì½ÂÆÀ ±ºÁ¶Å©·ç, °¡¿ä°è Á¤½Ä µ¥ºß (2024-05-05)
¡®¼± ³ÑÀº ÆÐ¹Ð¸®¡¯ ¾ÈÁ¤È¯, ÆøÅº ¹ß¾ð? ÀÌÇý¿ø ¡®Â¡¯! (2023-11-10)
KG ¸ðºô¸®Æ¼, Åä·¹½º EVXÀÇ LFP ¹èÅ͸® ¾ÈÀü¼º ÀÔÁõ (2023-12-22)
K-ÆÄ½ºÅ¸ ºê·£µå ÆÄ½ºÅ¸Ä¡¿ä, ¸Ô¹æ À¯Æ©¹ö ¡®¾¥´Ù¡¯ ÇùÂù (2023-10-10)
CEOs Vote Hybrid Work Flexibility as #1 Driver Underpinning ... (2023-10-12)
SKÅÚ·¹ÄÞ »óǰ, ¼­ºñ½º·Î ½º¸¶Æ®ÇÑ ¿©¸§ÈÞ°¡ (2015-07-22)
³­Ã» ¾Æµ¿ ¹× ÀÌÁÖ¹è°æ û¼Ò³âÀÇ ¹®Á¦ ¿µ¿ª ¹ß±¼ ¹× ÇØ°á (2024-05-29)
Æ÷ÅäÀ§Á¬, Ãâ½Ã 3³â ¸¸¿¡ ´©Àû »ç¿ëÀÚ 4000¸¸¸í µ¹ÆÄ (2023-11-03)
È£¸Å½ÇÀå¾ÖÀÎÁ¾ÇÕº¹Áö°ü-È­È«º´¿ø, Ãë¾à°èÃþ ¹«·á °Ç°­°ËÁø (2024-04-08)
2024 ÀüÁÖ °øÀ¯¼÷¹Ú ¿î¿µÀÚ ±³À° & â¾÷ ¼³¸íȸ (2024-06-20)
ÇÑÈ­ºÒ²ÉÇÕâ´Ü, Á¤±â¿¬ÁÖȸ ¡®´Ù½Ã, ºÒ²ÉÀ¸·Î¡¯ 2¿ù 6ÀÏ °³ÃÖ (2024-02-06)
Kenvue Becomes a Fully Independent Company Following Final S... (2023-08-24)
»ï¸é ÄÚ³ÊÀÔÁö ¾çÁֽà °íÀ¾Áö±¸ ¡®¿À¼ÇŸ¿ö¡¯ (2016-01-04)
ÇÏ·ç¾ßä, ÇÏ·ç¾ßä30À¸·Î ¸®ºê·£µù¡¦ ½ÅÁ¦Ç° 6Á¾ Ãâ½Ã (2024-07-12)
±×¶ó¿îµå½Ã¼Ò Àü½Ã ¿î¿µ»ç, 1000¾ï ¹ë·ù ½Ã¸®Áî A ÅõÀÚ À¯Ä¡ (2024-07-12)
¾÷ÅÙ¼Ç ¼±À², ¡¯°æ±¹Áö»ö ¾î¿ìµ¿¡¯ ÇѺ¹ ÀÔ°í ÀÎÁõ »çÁø (2016-01-17)
15¹ÌÅÍ Áܸ¶ÀÌÅ© ¼ÒÇü³ìÀ½±â ¡®Çʸ³½º º¸À̽º·¹ÄÚµµ¡¯ (2015-08-28)
ÇÑÈ­»ý¸í, º¸Çè°è¾à´ëÃâ °¡»ê±Ý¸® ÀÎÇÏ (2024-01-19)
GS25, ÀÚ»ç ¾Û È°¿ëÇÑ ¡®¸¶°¨ÇÒÀΡ¯ ¼­ºñ½º ·ÐĪ (2023-12-19)
1900°¡±¸ ´ë´ÜÁö ·¡¹Ì¾È ¸íÀÏ¿ª ¼Öº£´º (2016-07-20)
ExaGrid Earns Premier 5-Star Rating in 2024 CRN Partner Prog... (2024-04-01)
       [ÀÌÀü][1]....[623][624][625][626][627][628][629][630][631]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..